DIA391.36-5.21 -1.31%
SPX5,282.70+7.00 0.13%
IXIC16,286.45-20.71 -0.13%

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Benzinga·03/20/2025 12:18:13
Listen to the news

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Thursday.

Shares of JOYY Inc. (NASDAQ:YY) fell sharply in today's pre-market trading following weak quarterly sales.

JOYY reported quarterly earnings of $1.77 per share which beat the analyst consensus estimate of $1.18 per share. The company reported quarterly sales of $549.45 million which missed the analyst consensus estimate of $549.46 million by 0 percent. This is a 3.58 percent decrease over sales of $569.84 million the same period last year.

JOYY shares dipped 10.9% to $41.75 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Akebia Therapeutics, Inc. (NASDAQ:AKBA) shares fell 26.2% to $2.09 in pre-market trading after the company priced its $50 million public offering of 25 million common shares at $2 per share.
  • Maze Therapeutics, Inc (NASDAQ:MAZE) fell 11.8% to $10.70 in today's pre-market trading.
  • GH Research PLC (NASDAQ:GHRS) declined 7.2% to $11.01 in pre-market trading.
  • Enerflex Ltd. (NYSE:EFXT) fell 7.1% to $7.00 in pre-market trading after the company reported that Marc Rossiter has stepped down as President, CEO, and Director.
  • ZTO Express (Cayman) Inc. (NYSE:ZTO) declined 5.8% to $20.49 in pre-market trading.
  • Microchip Technology Incorporated (NASDAQ:MCHP) fell 5.5% to $51.54 in pre-market trading after the company announced an offering of $1.35 of billion depository shares.
  • UP Fintech Holding Limited (NASDAQ:TIGR) fell 4.7% to $9.21 in pre-market trading.
  • Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 2.5% to $30.00 in pre-market trading.

Now Read This:

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.